Results: 1-8 |
Results: 8

Authors: Brophy, VH Hastings, MD Clendenning, JB Richter, RJ Jarvik, GP Furlong, CE
Citation: Vh. Brophy et al., Polymorphisms in the human paraoxonase (PON1) promoter, PHARMACOGEN, 11(1), 2001, pp. 77-84

Authors: Jarvik, GP Rozek, LS Brophy, VH Hatsukami, TS Richter, RJ Schellenberg, GD Furlong, CE
Citation: Gp. Jarvik et al., Paraoxonase (PON1) phenotype is a better predictor of vascular disease than is PON1(192) or PON1(55) genotype, ART THROM V, 20(11), 2000, pp. 2441-2447

Authors: Li, WF Costa, LG Richter, RJ Hagen, T Shih, DM Tward, A Lusis, AJ Furlong, CE
Citation: Wf. Li et al., Catalytic efficiency determines the in-vivo efficacy of PON1 for detoxifying organophosphorus compounds, PHARMACOGEN, 10(9), 2000, pp. 767-779

Authors: Brophy, VH Jarvik, GP Richter, RJ Rozek, LS Schellenberg, GD Furlong, CE
Citation: Vh. Brophy et al., Analysis of paraoxonase (PON1) L55M status requires both genotype and phenotype, PHARMACOGEN, 10(5), 2000, pp. 453-460

Authors: Furlong, CE Li, WF Brophy, VH Jarvik, GP Richter, RJ Shih, DM Lusis, AJ Costa, LG
Citation: Ce. Furlong et al., The PON1 gene and detoxication, NEUROTOXICO, 21(4), 2000, pp. 581-587

Authors: Furlong, CE Li, WF Richter, RJ Shih, DM Lusis, AJ Alleva, E Costa, LG
Citation: Ce. Furlong et al., Genetic and temporal determinants of pesticide sensitivity: Role of paraoxonase (PON1), NEUROTOXICO, 21(1-2), 2000, pp. 91-100

Authors: Richter, RJ Furlong, CE
Citation: Rj. Richter et Ce. Furlong, Determination of paraoxonase (PON1) status requires more than genotyping, PHARMACOGEN, 9(6), 1999, pp. 745-753

Authors: Costa, LG Li, WF Richter, RJ Shih, DM Lusis, A Furlong, CE
Citation: Lg. Costa et al., The role of paraoxonase (PON1) is the detoxication of organophosphates andits human polymorphism, CHEM-BIO IN, 120, 1999, pp. 429-438
Risultati: 1-8 |